In this exclusive interview for World Pharma Today, Phastar’s Head of Strategic Consulting, Billy Amzal, shares his career insights, regulatory perspectives, and how data-driven strategies are accelerating smarter, safer, and more impactful healthcare decisions.
”We are increasingly seeing regulatory agencies specify the context of use for novel approach methodologies such as Bayesian statistics. I believe this acceleration is set to continue. Better access to fit-for-purpose data, via platforms like the European Health Data Space, will combine with improved methodological guidance and more precedents to rely upon.”